ReviewJournal of molecular medicine (Berlin, Germany)2025
Unveiling the roles of CTRP family in cardiac remodeling.
Review in Journal of molecular medicine (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hormonal crossroads of the heart: from classic endocrine regulation to cardiac hormone secretion: an updated review.Journal of endocrinological investigation · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The C1q/TNF-related protein family (CTRPs), a group of adipokines sharing structural homology with adiponectin (APN), have emerged as crucial regulators of metabolic and cardiovascular homeostasis. As secreted proteins with pleiotropic functions, CTRPs are involved in various physiological and pathological processes through autocrine, paracrine, and endocrine mechanisms. Cardiac remodeling, a central pathological process in cardiovascular diseases (CVDs) triggered by various cardiac injuries, involves structural and functional alterations in the myocardium. Emerging evidence has demonstrated that CTRPs play dual roles in cardiac remodeling, either ameliorating or exacerbating this process. Mechanistically, CTRPs modulate oxidative stress, inflammation, and metabolic reprogramming, all of which regulate cardiac hypertrophy and fibrosis. This review provides a systematic overview of the functional roles of CTRPs in cardiac remodeling, with a focus on their structural features, tissue distribution, and receptor-mediated signaling pathways. Furthermore, we discuss the therapeutic potential of CTRPs as biomarkers and molecular targets in CVDs, emphasizing the necessity of mechanistic and translational studies to advance clinical applications. The elucidation of CTRP-mediated pathways may offer novel insights into the pathogenesis of cardiac remodeling and facilitate the development of therapeutic strategies for treating CVDs.
Indexed as
Identifiers
40579606What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.